BridgeMD
New treatment option for Acute Kidney Injury
Official title UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events
ClinicalTrials.gov ID: NCT05806645
What this study is testing
- What it's testing
- Nearly one in ten people who are hospitalized in Canada develop a complication with sudden loss of kidney function, called acute kidney injury (AKI). AKI may lead to other severe health problems after discharge home, such as kidney failure requiring dialysis treatment, heart failure, heart attacks, stroke, and even premature death.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- (all of)
- Age ≥ 18 years old
- Hospitalized at site using AHS EHR
- Acute Kidney Injury (Stage 1-3) identified in hospital per KDIGO guideline criteria
You likely can't join if
- (any of)
- Pre-hospitalization advanced CKD: eGFR\<30 mL/min/1.73m2
- Pre-hospitalization dialysis
- Very low risk (\<1% risk) of advanced CKD
- Non-Alberta resident
- Palliative goals of care
See the full eligibility criteria
- (all of)
- Age ≥ 18 years old
- Hospitalized at site using AHS EHR
- Acute Kidney Injury (Stage 1-3) identified in hospital per KDIGO guideline criteria
- (any of)
- Pre-hospitalization advanced CKD: eGFR\<30 mL/min/1.73m2
- Pre-hospitalization dialysis
- Very low risk (\<1% risk) of advanced CKD
- Non-Alberta resident
- Palliative goals of care
- Enrolled in the UPTAKE VC Trial
- Admitted under a nephrologist at time of discharge
- Dialysis on at least 2 days in the last week prior to discharge
- Receiving apheresis
- Kidney transplant recipient
- Kidney transplant donor
- Diagnosis of Glomerulonephritis
- Cirrhosis AND complication of cirrhosis in medical history or active problem list (ascites, varices, hepatic encephalopathy, hepatorenal syndrome)
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
- Edmonton, Alberta, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada; Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.